title: Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents.
authors.affiliation: COR Therapeutics, Inc., South San Francisco, California 94080, USA. rscarborough@corr.com
authors.forename: R M
authors.initials: RM
authors.lastname: Scarborough
authors.forename: D D
authors.initials: DD
authors.lastname: Gretler
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000737:chemistry / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015195:Drug Design; D005343:Fibrinolytic Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D016023:Integrins / Q000037:antagonists & inhibitors*; D018716:Molecular Mimicry; D010455:Peptides / Q000737:chemistry / Q000302:isolation & purification / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D012910:Snake Venoms / Q000737:chemistry
chemical_list: D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D016023:Integrins; D010455:Peptides; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D012910:Snake Venoms